Title: Typhoid Fever Vaccines Market Forecast to 2027
1Typhoid Fever Vaccines Market
Typhoid Fever Vaccines Market Forecast to 2027 -
COVID-19 Impact and Global Analysis by Vaccine
Type (Live Attenuated Vaccine, Capsular
Polysaccharide Vaccines, Conjugate Vaccine,
Others) Route of administration (Oral,
Injectable), and Geography.
2Current and future Market Scenario
Typhoid Fever Vaccines Market
- According to our new market research study
Typhoid fever vaccines Market to 2027 Global
Analysis and Forecast by vaccine type and route
of administration, the market is expected to
reach US 525.32 million by 2027 from US 262.81
million in 2019. The market is estimated to grow
with a CAGR of 9.3 from 2020 to 2027. The report
highlights trends prevailing in the market, and
drivers and hindrances pertaining to the market
growth.
3Market Segments
Typhoid Fever Vaccines Market
Route of administration Oral
Injectable
By Vaccine Type Live Attenuated
Vaccine Capsular Polysaccharide
Vaccines Conjugate Vaccine
4Leading Players
Typhoid Fever Vaccines Market
Company Profiles in Typhoid Fever Vaccines
Market are Shanghai institute of biological
products co., ltd. Paxvax Inc. PT Bio
Farma BIO-MED BHARAT BIOTECH Sanofi GlaxoSmithKlin
e plc. Prokarium Ltd. SCANDINAVIAN BIOPHARMA
5Typhoid Fever Vaccines Market
Access Full Research Report at
https//www.theinsightpartners.com/reports/typhoid
-vaccines-market
Thank You!